Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M185Revenue $M7.0Net Margin (%)-1,889.7Z-Score-0.6
Enterprise Value $M136EPS $-4.6Operating Margin %-1,862.7F-Score2
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-1,889.7Higher ROA y-yN
Price/Book4.010-y EBITDA Growth Rate %0Quick Ratio14.6Cash flow > EarningsY
Price/Sales49.25-y EBITDA Growth Rate %0Current Ratio14.6Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-65.2Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-151.5Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M19.7ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with ARGS

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

ARGS is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


ARGS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Pharmstandard International S.10% Owner 2014-02-12Buy1,275,000$817.38view
Underdown Brian J.Director, 10% Owner 2014-02-12Buy40,497$817.38view
Cooperatieve AAC LS U.A.10% Owner 2014-02-12Buy36,416$817.38view
Birner HubertDirector, 10% Owner 2014-02-12Buy39,873$817.38view
van Deventer SanderDirector, 10% Owner 2014-02-12Buy36,416$817.38view
Mizuho Capital No. 3 Limited P10% Owner 2014-02-06Sell0$017.38view
Kyowa Hakko Kirin Co Ltd10% Owner 2014-02-06Sell0$017.38view
TFG USA, LLC10% Owner 2014-02-06Sell0$017.38view

Press Releases about ARGS :

    Quarterly/Annual Reports about ARGS:

      News about ARGS:

      Articles On GuruFocus.com
      Weekly 3-Year Low Highlights: VCRA, CLUB, ARGS, ONTX, BOTA Jun 08 2014 

      More From Other Websites
      ARGOS THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers Dec 11 2014
      Argos Therapeutics to Present at the 26th Annual Piper Jaffray Healthcare Conference Nov 25 2014
      Argos Therapeutics to Present at the 26th Annual Piper Jaffray Healthcare Conference Nov 25 2014
      Argos Therapeutics Receives 2014 Red Herring North America Top 100 Award Nov 24 2014
      Argos Therapeutics Receives 2014 Red Herring North America Top 100 Award Nov 24 2014
      ARGOS THERAPEUTICS INC Financials Nov 21 2014
      Argos Therapeutics (ARGS) Jumps: Stock Gains 7.4% Nov 19 2014
      ARGOS THERAPEUTICS INC Files SEC form 10-Q, Quarterly Report Nov 14 2014
      Argos Therapeutics Reports Third Quarter 2014 Financial Results and Operational Highlights Nov 13 2014
      ARGOS THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Change in... Nov 13 2014
      Argos Therapeutics Reports Third Quarter 2014 Financial Results and Operational Highlights Nov 13 2014
      1 Way To Search For The 'Next Big Thing' In Biotech Nov 13 2014
      Philippe Van Holle Joins Argos Therapeutics Board of Directors Nov 13 2014
      Philippe Van Holle Joins Argos Therapeutics Board of Directors Nov 13 2014
      Q3 2014 Argos Therapeutics Inc Earnings Release - After Market Close Nov 13 2014
      Argos Therapeutics to Present at the Stifel 2014 Healthcare Conference Nov 12 2014
      Argos Therapeutics to Present at the Stifel 2014 Healthcare Conference Nov 12 2014
      Argos Therapeutics to Hold Third Quarter 2014 Financial Results Conference Call on Thursday,... Nov 06 2014
      Argos Therapeutics to Hold Third Quarter 2014 Financial Results Conference Call on Thursday,... Nov 06 2014
      Invetech and Argos Therapeutics Announce Agreement to Support Global Production of Fully... Nov 05 2014

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK